ECONOMIC IMPACT OF USING FESOTERODINE FOR THE TREATMENT OF OVERACTIVE BLADDER IN VULNERABLE ELDERLY POPULATION IN THE UNITED STATES

被引：0
|
作者：
Qin, L. [1 ]
Luo, X. [2 ]
Zou, K. H. [2 ]
Snedecor, S. J. [1 ]
机构：
[1] Pharmerit Int, Rotterdam, Netherlands
[2] Pfizer Inc, New York, NY USA
来源：
NEUROUROLOGY AND URODYNAMICS | 2015年 / 34卷
关键词：
INCONTINENCE;
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
498
引用
收藏
页码：S412 / S413
页数：2
相关论文
共 50 条
  • [1] Economic impact of using fesoterodine for the treatment of overactive bladder with urge urinary incontinence in a vulnerable elderly population in the United States
    Qin, Lei
    Luo, Xuemei
    Zou, Kelly H.
    Snedecor, Sonya J.
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (03) : 229 - 235
  • [2] Fesoterodine for the treatment of overactive bladder
    Belavic, Jennifer M.
    [J]. NURSE PRACTITIONER, 2009, 34 (08): : 14 - 15
  • [3] Fesoterodine for the Treatment of Overactive Bladder
    Tzefos, Maria
    Dolder, Christian
    Olin, Jacqueline L.
    [J]. ANNALS OF PHARMACOTHERAPY, 2009, 43 (12) : 1992 - 2000
  • [4] AN ECONOMIC EVALUATION OF FESOTERODINE IN THE TREATMENT OF OVERACTIVE BLADDER (OAB) IN KOREA
    Jo, C.
    Lee, S. J.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A200 - A200
  • [5] Role of fesoterodine in the treatment of overactive bladder
    Mansfield, Kylie J.
    [J]. RESEARCH AND REPORTS IN UROLOGY, 2010, 2 : 1 - 9
  • [6] Overactive bladder in the vulnerable elderly
    Wolff, Gillian F.
    Kuchel, George A.
    Smith, Phillip P.
    [J]. RESEARCH AND REPORTS IN UROLOGY, 2014, 6 : 131 - 138
  • [7] Treatment of Overactive Bladder in the Elderly Female: The Case for Trospium, Oxybutynin, Fesoterodine and Darifenacin
    Scott C. McFerren
    Alex Gomelsky
    [J]. Drugs & Aging, 2015, 32 : 809 - 819
  • [8] Treatment of Overactive Bladder in the Elderly Female: The Case for Trospium, Oxybutynin, Fesoterodine and Darifenacin
    McFerren, Scott C.
    Gomelsky, Alex
    [J]. DRUGS & AGING, 2015, 32 (10) : 809 - 819
  • [9] Evaluation of fesoterodine fumarate for the treatment of an overactive bladder
    Mock, Stephen
    Dmochowski, Roger R.
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (12) : 1659 - 1666
  • [10] FESOTERODINE IS COST-EFFECTIVE FOR THE TREATMENT OF OVERACTIVE BLADDER: RESULTS OF AN ECONOMIC MODEL
    Kelleher, C.
    Snedecor, S. J.
    Botteman, M. F.
    Lee, R.
    Najib, H.
    Weinstein, D.
    Trocio, J. N.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A652 - A652
12345